Skip to main content

Table 3 Reported complete excision rates of benign, ADH, DCIS, and IDC lesions

From: A systematic review on the use of the breast lesion excision system in breast disease

First author

Definition complete excision

Benign complete excision rate n/N (%)

ADH complete excision rate n/N (%)

DCIS complete excision rate n/N (%)

IDC complete excision rate n/N (%)

Total complete excision rate n/N (%)

Sie et al. (4)

No residual disease at surgical specimen

NA

21/32 (65.6)

1/115 (0.9)

NA

22/147 (15)

Killebrew et al. (9)

BLES produced a diagnosis of DCIS or ADH and surgical biopsy resulted in a benign diagnosis with no evidence of IDC, DCIS, or ADH

NA

NA

12/31 (38.7)

NA

12/31 (38.7)

Allen et al. (5)

No residual disease at surgical specimen

5/6 (83.3)

NA

4/6 (66.7)a

3/6 (50)b

12/18 (66.7)

Seror et al. (10)

No residual disease at surgical specimen

0/1 (0)

2/9 (22.2)c

11/27 (40.7)

1/7 (14.3)d

0/2 (0)e

14/46 (30.4)

Diepstraten et al. (11)

NA

NA

NA

1/19 (5.3)f

NA

1/19 (5.3)

Whitworth et al. (6)

NA

NA

NA

NA

NA

NA

Razek et al. (12)

1 mm free margin after BLES

NA

20/24 (83.3)g

6/8 (75)

3/6 (50)

29/38 (76.3)

Medjhoul et al. (13)

No residual disease at surgical specimen

NA

3/4 (75)

NA

0/10 (0)

3/14 (21.4)

Al-Harethee et al. (7)

NA

NA

NA

NA

NA

NA

Allen et al. (14)

No residual disease at surgical specimen

NA

3/6 (50)

6/11 (54.5)

5/8 (62.5)

14/25 (56)

Al-Harethee et al. (15)

NA

NA

NA

NA

NA

NA

Scaperrotta et al. (16)

No residual disease at surgical specimen

NA

NA

16/32 (50)

1/3 (33.3)d

2/4 (50)h

19/39 (48.7)

Graham (17)

NA

NA

NA

NA

NA

NA

Milos et al. (20)

BLES produced a HRL or malignant lesion and the surgical specimen did not contain any remnants of the initial malignant or high-risk lesion

NA

8/14 (57.1)i

3/10 (30)

4/10 (40)

15/34 (44.1)

Sklair-Levy et al. (21)

NA

NA

NA

NA

NA

NA

Papapanagiotou et al. (22)

No residual disease at surgical specimen

NA

NA

4/5 (80)

21/45 (46.7)

25/50 (50)

Niinikoski et al. (23)

Complete excision was based on histological margin status of the BLES sample

19/43 (44.2)j

6/10 (60)i

2/3 (66.7)

0/2 (0)

27/58 (46.6)

  1. Values as presented in the articles; ADH atypical ductal hyperplasia; BLES breast lesion excision system; DICS ductal carcinoma in situ; HRL high-risk lesions; IDC invasive ductal carcinoma; n number of (benign/ADH/DCIS or IDC) complete excisions; N total number of initially benign/ADH/DCIS or IDC; NA not available;
  2. aLow-grade DCIS
  3. bIDC and other malignant lesions
  4. cLesions with cell atypia
  5. dIDC complete excision rate
  6. eInvasive lobular carcinoma (ILC) complete excision rate
  7. fBased on post-biopsy mammographic follow-up and specimen radiography
  8. gADH, atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS)
  9. hDCIS with micro-invasion complete excision rate
  10. iHigh-risk lesion complete excision rate
  11. jBenign intraductal papilloma